![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1556, 2006-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The trials and tribulations of paediatric HIV research
Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ethical issues in paediatric cancer trials
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Topiramate [Topamax; Ortho-McNeil Neurologics] has been granted paediatric exclusivity
Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug trials in paediatric patients: continuing issues
Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Health policy on drug trials in paediatric patients
Inpharma, Vol. 1, Iss. 1363, 2002-01 ,pp. :